Loading clinical trials...
Loading clinical trials...
General consensus and contemporary guidelines, recommend surgery for primary hyperparathyroidism (pHPT)for all patients below the age of 50, for patients with pronounced hypercalcemia and for patients...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Region Skane
NCT06523582 · Neuroendocrine Neoplasm, Neuroendocrine Neoplasm of Gastrointestinal Tract, and more
NCT05761743 · Primary Hyperparathyroidism, Type 2 Diabetes
NCT07444723 · Primary Hyperparathyroidism, Parathyroid Cancer, and more
NCT04299425 · Parathyroid Adenoma, Parathyroid Neoplasms, and more
NCT04608253 · Primary Hyperparathyroidism, Primary Hyperparathyroidism Due to Adenoma
Skåne University Hospital, Department of Surgery, Lund
Lund
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions